Clinical significance of Serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 544-549

  Osada, Shinji ^a   Kanematsu, Masayuki ^a   Imai, Hisashi ^a   Goshima, Satoshi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

C Met hepatocyte growth factor receptor; Hepatocellular carcinoma; Hepatocyte growth factor; Intrahepatic metastasis; Multicentric, protein induction

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

AGED; ARTICLE; CANCER RECURRENCE; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; MALE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; TUMOR MARKERS, BIOLOGICAL;

EID: 44349155339     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Arii S, Yamaoka Y, Futagawa S: Results of surgical and non-surgical treatment for small sized hepatocellular carcinomas; a retrospective and nationwide survey in Japan. Hepatology 2000; 32:1224-1229.
2. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, Watanabe G, Tsurumaru M: Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71:19-25.
3. Yamamoto J, Kosuge T, Takayama T: Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1998; 83:1219-1222.
4. Kubo S, Yamamoto T, Ikebe T, Shuto T, Hirohashi K, Tanaka H, Tsukamoto T, Wakasa K, Kinoshita H: Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C. Jpn J Cancer Res 1999; 90:1076-1080.
5. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, Yagura K, Ohyama T, Nishio K, Ohashi K, Sho M, Yamada T, Nakano H: Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy: result of multivariate analysis. Ann Surg 1996; 224:591-595.
6. Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S: u-PA and c-MET mRNA expression is coordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Int J Cancer 2000; 87:644-649.
7. Luo YQ, Wu MC, Cong WM: Gene expression of hepatocyte growth factor and its receptor in HCC and nontumorous liver tissues. World J Gastroenterol 1999; 5:119-121.
8. Anthony PP, Ishak K, Nayak NC: The morphology of cirrhosis. J Clin pathol 1978; 31:395-414.
9. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S: Surgery for small liver cancers. Semin Surg Oncol 1993; 9:293-298.
10. Osada S, Saji S, Kuno T: Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma. J Surg Oncol 2004; 85:48-54.
11. Osada S, Osada K, Carr BI: Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins. J Mol Biol 2001; 314:765-772.
12. Iwatsuki S, Gordon RD, Shaw BW, Starzl TE: Role of liver transplantation in cancer therapy. Ann Surg 1985; 202:401-407.
13. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T, Settmacher U, Neuhaus P: Vascular invasion and histopathological grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33:1080-1086.
14. Schafer DF, Sorrell MF: Hepatocellular carcinoma. Lancet 1999; 353:1253-1257.
15. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S: Liver transplantation for hepatocellular carcinoma. World J Surg 1995; 19:53-58.
16. Reyes JD, Carr B, Dvorchik I, Kocoshis S, Jaffe R, Gerber D, Mazariegos GV, Bueno J, Selby R: Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000; 136:795-799.
17. Suenaga M, Sugiura H, Kokubu Y: Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery 1994; 115:452-457.
18. Hanahan H, Weinberg R A: The hallmarks of cancer. Cell 2000; 100:57-70.
19. Korn WM: Moving toward an understanding of the metastatic process in hepatocellular carcinoma. World J Gastroenterol 2001; 7:777-778.
20. Parr C, Jiang WG: Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 2001; 19:857-863.
21. Schmidt C, Bladt F, Goedecke S, et al: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373:699-702.
22. Riordan SM, Williams R: Acute liver targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32:63-76.
23. de Jong KP, van Gameren MM, Bijizet J: Recombinant human interleukin-6 induces hepatocyte growth factor production in cancer patients. Scand J Gastroenterol 2001; 36:636-640.
24. Noguchi O, Enomoto N, Ikeda T: Gene expression of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma. J Hepatol 1996; 24:286-292.
25. Osada S, Nakashima S, Saji S, Nakamura T, Nozawa Y: Hepatocyte growth factor (HGF) mediates the sustained formation of 1,2-diacylglycerol via phophatidylcholinephopholipase C in cultured rat hepatocytes. FEBS lett 1992; 297:271-274.
26. Furge KA, Zhang YW, Vande Woude GF: Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 2000; 19:5582-5589.
27. Hu RH, Lee PH, Yu SC, Sheu JC, Lai MY: Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma HepatoGastroenterol 1999; 46:1842-1847.
28. Tomiya T, Ogata I, Fujiwara K: Transforming growth factor-alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol 1998; 153:955-961.
29. Selden C, Farnaud S, Ding SF, Habib N, Foster C, Hodgson HJ: Expression of hepatocyte growth factor mRNA and c-met mRNA (hepatocyte growth factor receptor) in human liver tumors. J Hepatol 1994; 21:227-234.
30. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T: Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21:106-112.
31. Deveau M, Scotte M, Francois A: Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog 2003; 36:130-141.
32. Chijiiwa K, Saiki S, Tamaka M: Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy. Hepatogastoenterol 2002; 49:467-471.
33. Nonami T, Isshiki K, Katoh H, Kishimoto W, Harada A, Nakao A, Takagi H: The potential role of post-operative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg 1991; 213:222-226.
34. Osada S, Saji S: Novel approach to cancer therapy: the application of signal transduction to anti-cancer drug. Curr Med Chem-Anti-Cancer Agents 2003; 3:119-131.
35. Osada S, Carr BI: Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line. J Hepatol 2001; 34:676-682.